19,700 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Bought by Mill Creek Capital Advisors LLC

Mill Creek Capital Advisors LLC purchased a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 19,700 shares of the pharmacy operator’s stock, valued at approximately $184,000.

A number of other large investors have also recently added to or reduced their stakes in WBA. International Private Wealth Advisors LLC raised its position in shares of Walgreens Boots Alliance by 14.5% in the fourth quarter. International Private Wealth Advisors LLC now owns 14,730 shares of the pharmacy operator’s stock valued at $137,000 after purchasing an additional 1,870 shares during the period. Newbridge Financial Services Group Inc. acquired a new position in Walgreens Boots Alliance in the 4th quarter valued at about $184,000. Empowered Funds LLC raised its holdings in Walgreens Boots Alliance by 16.5% in the 4th quarter. Empowered Funds LLC now owns 26,084 shares of the pharmacy operator’s stock valued at $243,000 after acquiring an additional 3,685 shares during the period. Cidel Asset Management Inc. lifted its position in Walgreens Boots Alliance by 29.8% during the fourth quarter. Cidel Asset Management Inc. now owns 61,847 shares of the pharmacy operator’s stock worth $577,000 after acquiring an additional 14,191 shares during the last quarter. Finally, Golden State Wealth Management LLC bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $26,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Analyst Upgrades and Downgrades

WBA has been the topic of a number of recent research reports. Truist Financial lowered their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Bank of America increased their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research report on Monday, January 13th. UBS Group boosted their target price on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. TD Cowen lowered their price target on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research report on Tuesday, October 22nd. Finally, Jefferies Financial Group cut their price objective on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a report on Wednesday, October 23rd. Four research analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, Walgreens Boots Alliance has a consensus rating of “Hold” and an average price target of $13.19.

Walgreens Boots Alliance Price Performance

NASDAQ WBA opened at $9.36 on Wednesday. The business has a fifty day moving average price of $10.24 and a two-hundred day moving average price of $9.79. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $22.96. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same period in the prior year, the company earned $0.66 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 7.6% on a year-over-year basis. As a group, research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.